Mirati Ther (MRTX) Financials

$58.70

$0.00 (0.00%)

As on 23-Jan-2024 09:30EDT

Market cap

$4,118 Mln

Revenue (TTM)

$38 Mln

P/E Ratio

--

P/B Ratio

4.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	38.19	12.44	72.09	13.40	3.34	12.93
Cost of Revenue	4.13	0.60	--	--	--	--
Gross Profit	34.06	11.84	72.09	13.40	3.34	12.93
Operating Expenses	798.93	771.43	645.27	382.76	225.44	115.55
Operating Profit (EBIT)	-764.87	-759.59	-573.18	-369.36	-222.10	-102.63
Other Income	19.59	--	-5.30	11.43	8.85	4.21
Profit before Tax	-725.62	-740.36	-578.49	-357.94	-213.26	-98.42
Provision for Tax	-10.10	0.51	3.30	-0.51	-0.66	4.21
Profit after Tax (Net Income)	-716.64	-740.87	-581.78	-357.43	-212.60	-98.42
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-563.97	-740.87	-581.78	-357.94	-213.26	-98.42

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	946.47	996.52	1,397.04	1,360.79	382.30	201.58
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	45.86	46.68	48.06	43.87	1.00	0.73
Current Liabilities	137.38	159.45	143.66	71.47	48.91	26.15
Total Liabilities	1,267.09	1,202.65	1,588.75	1,476.13	432.20	228.45

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	93.63	93.69	80.77	72.49	7.79	1.79
Current Assets	1,036.08	1,108.96	1,507.98	1,403.64	424.41	226.66
Total Assets	1,267.09	1,202.65	1,588.75	1,476.13	432.20	228.45
Total Debt*	50.22	51.51	45.88	41.91	--	--
Net Current Assets	898.70	949.51	1,364.33	1,332.17	375.50	200.51

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-570.57	-388.80	-271.53	-147.73	-70.10
Cash Flow from Investing Activities	--	225.80	-588.90	-139.86	-176.14	-145.77
Cash from Financing Activities	--	166.94	505.22	1,250.71	338.03	140.85
Net Cash Inflow / Outflow	--	--	-472.48	839.33	14.16	-75.01

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-12.06	-12.85	-10.85	-7.36	-5.39	-3.03
Cash EPS ($)	--	-12.80	-10.82	-7.34	-5.38	-3.02
Adjusted Book Value ($)	--	17.28	26.06	28.01	9.69	6.20
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-9.89	-7.25	-5.59	-3.74	-2.16
Free Cash Flow per Share ($)	--	-9.98	-7.43	-5.68	-3.78	-2.16

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-59.48	-40.89	-40.05	-72.82	-57.08
ROE (%)	-79.23	-61.91	-42.19	-41.01	-72.82	-57.08
ROA (%)	-53.14	-53.08	-37.96	-37.46	-64.36	-51.03
EBIT Margin (%)	-2,010.82	-6,107.98	-795.07	-2,756.85	-6,659.79	-793.96
Net Margin (%)	-1,240.19	-5,957.44	-871.09	-1,439.84	-1,745.03	-574.37
Cash Profit Margin (%)	0.16	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	223.63	-0.83	4.38	3.02	-0.74	--
EBIT Growth (%)	-3.01	-32.52	-55.18	-66.30	-116.42	-43.46
Net Profit Growth (%)	3.53	-27.34	-62.77	-68.12	-116.01	-39.63
EPS Growth (%)	10.46	-0.18	-0.48	-0.37	-0.78	-0.15
Book Value Growth (%)	-27.49	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-3.53	-13.52	-29.86	-23.91	-14.02
Price / Book Value	4.35	2.62	5.63	7.84	13.30	6.84
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-4.12	-2.09	-11.23	-23.92	-19.38	-9.44
Close Price ($)	43.56	45.31	146.69	219.64	128.86	42.42
High Price ($)	101.30	151.15	225.47	249.42	130.01	65.35
Low Price ($)	27.30	32.96	127.12	66.01	40.91	17.15
Market Cap ($ Cr)	4,117.67	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.05	0.03	0.03	--	--
Short term debt to equity ratio	0.01	0.01	0.00	0.00	0.13	0.09
Current Ratio	7.54	6.96	10.50	19.64	8.68	8.67
Quick Ratio	7.40	6.94	10.51	19.67	8.71	8.70
Interest Coverage	-77.19	-42.30	-136.02	--	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	52.71	6.96	3.49	17.20	46.96	5.94
Asset Turnover	0.03	0.01	0.05	0.01	0.01	0.07
Receivable days	--	49.61	12.20	52.75	127.81	14.20
Inventory Days	--	154.32	--	--	--	--
Payable days	--	22,531.06	--	--	--	--
Cash Conversion Cycle	--	-22,327.13	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.